Return-to-Play Post-Myocarditis Safety Calculator
Clinical Readiness Assessment
Enter follow-up findings to identify issues requiring specialist review before return to strenuous exercise or competitive sport.
RTPReview
Review
Assessment outcome
Clinical recommendation
How to interpret this assessment
This is a conservative decision-support checklist, not a validated risk score and not an automatic sports-clearance instrument. It identifies unresolved findings for review by the treating cardiology or sports-cardiology team.
Key clinical considerations
- Athletes should not participate in strenuous or competitive sport while symptoms or active myocardial inflammation/edema persist.
- Assessment before return should consider ventricular function, cardiac biomarkers, CMR when indicated, ambulatory rhythm monitoring, and exercise testing.
- Traditional guidance commonly recommends 3–6 months away from strenuous exercise for clinical myocarditis, followed by reassessment. The 2025 AHA/ACC statement allows earlier return in selected athletes when specified criteria are satisfied.
- Persistent LGE alone does not automatically prohibit participation when LV systolic function is normal and clinically relevant arrhythmias are absent; individualized assessment and longitudinal surveillance remain important.
- This checklist does not capture every risk modifier, including baseline ventricular dysfunction, myocarditis severity or etiology, genetic substrate, LGE extent/pattern, and sport-specific demands.
Why there is no automatic “cleared” result
Guidelines require integrated clinical assessment. This checklist flags issues for review rather than replacing specialist judgement or certifying clearance.
References
Drazner MH, Bozkurt B, Cooper LT Jr, et al.2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.10.080
Kim JH, Baggish AL, Levine BD, et al.Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2025;151:e716–e761. doi:10.1161/CIR.0000000000001297
Clinical disclaimer: For educational and clinical decision-support use only. This tool is not a substitute for individualized assessment by a qualified clinician and must not be used as sole authorization to resume exercise or competitive sport. Follow local protocols and applicable guidance. Seek urgent assessment for chest pain, syncope, new dyspnea, sustained palpitations, or clinical deterioration.
PERSONAL WORKSPACE
Clinical notes
Document key findings and keep a structured record for your own reference.
Private by design. Notes are stored in this browser on this device only. They are not uploaded to Appcardio.
Export or share this note
PERSONAL WORKSPACE
My notes
Review, edit, or remove notes saved in this browser.
Stored locally on this device
QUALITY & SAFETY
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.
Please describe the issue clearly. For calculation concerns, include the input values and expected result where possible.